Comment from The Geneva Foundation, HHS-OPHS-2018-0021, HHS-OPHS-2018-0021-0001, N/A

The Geneva FoundationOtherIndividual
Summary: The commenter submitted a research subject consent form for a clinical trial involving an investigational drug for spinal cord injury. The document does not express a position on the proposed federal action regarding the posting of consent forms.
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of MT-3921 in Subjects with Acute Traumatic Cervical Spinal Cord Injury - Brooke Army Medical Center/Dr. Rizzo

View on Regulations.gov